InvestorsHub Logo
Followers 33
Posts 2840
Boards Moderated 2
Alias Born 10/24/2015

Re: None

Tuesday, 03/14/2023 9:48:00 PM

Tuesday, March 14, 2023 9:48:00 PM

Post# of 265
CTX112 and CTX131: Next-generation CRISPR/Cas9-engineered allogeneic (allo) CAR T cells incorporating novel edits that increase potency and efficacy in the treatment of lymphoid and solid tumors https://www.abstractsonline.com/pp8/#!/10828/presentation/2975
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRSP News